- Home
- AVTX vs GOOS Comparison
AVTX vs GOOS Comparison
Compare AVTX & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | GOOS |
|---|---|---|
| Founded | 2011 | 1957 |
| Country | United States | Canada |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.6M | 931.6M |
| IPO Year | 2015 | 2016 |
Fundamental Metrics
Financial Performance| Metric | AVTX | GOOS |
|---|---|---|
| Price | $16.51 | $7.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $40.57 | $12.60 |
| AVG Volume (30 Days) | 856.9K | ★ 862.3K |
| Earning Date | 05-08-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | $12.21 |
| Revenue Next Year | N/A | $5.16 |
| P/E Ratio | ★ N/A | $75.22 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $10.70 | $7.36 |
| 52 Week High | $24.27 | $14.69 |
Technical Indicators
Market Signals| Indicator | AVTX | GOOS |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 39.67 |
| Support Level | $15.29 | N/A |
| Resistance Level | $16.80 | $8.32 |
| Average True Range (ATR) | 1.00 | 0.25 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 23.14 | 29.17 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.